1 / 23

Enterobacteriaceae

Enterobacteriaceae. A. General characteristics 1. Pathogenic genera: human colonizers or pathogens 2. Non-pathogenic genera: human colonizers or environmentals 3. Oxidase negative, glucose fermenters, grow on MAC. B. Epidemiology 1. Reservoirs a. Inhabit human GI tract

brone
Télécharger la présentation

Enterobacteriaceae

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Enterobacteriaceae A. General characteristics 1. Pathogenic genera: human colonizers or pathogens 2. Non-pathogenic genera: human colonizers or environmentals 3. Oxidase negative, glucose fermenters, grow on MAC

  2. B. Epidemiology • 1. Reservoirs • a. Inhabit human GI tract • b. Inhabit GI tract of other animals • c. Environmental organisms • d. Zoonotic pathogens (cause disease in animals) • e. Only present during disease • 2. Transmission • a. Endogenous infections from patient’s own strain • b. Person to person • c. Ingestion of contaminated food or water • d. Vector-borne

  3. C. Pathogenesis and spectrum of disease • 1. Overt pathogens • a. Salmonella spp.: GI, bacteremia and extraintestinal infections, enteric fever (typhoid fever) • b. Shigella spp.: dysentery • c. Yersinia pestis: “black” plague • 2. Opportunistic pathogens • a. Citrobacter spp., Enterobacter spp., Klebsiella spp., Proteus spp., and Serratia spp. • b. can be very pathogenic, but usually only in immunocompromised • 3. Eschericia coli • a. more pathogenic than opportunists; some strains are overt pathogens • TABLE 25-2

  4. D. Laboratory diagnosis • 1. Specimen collection, transport, processing • a. No special considerations for these organisms • 2. Direct detection methods • a. No specific procedures for routine enterics • 3. Culture and identification • a. Media • i. BAP, CAP, Mac all support growth • large gray smooth on BAP, CAP • TABLE 25-3 • ii. CIN agar for selection of Yersinia • iii. Hektoen for Salmonella/Shigella • iv. MacConkey-Sorbitol: E. coli O157 can’t ferment sorbitol

  5. Gram stain of enteric Gram-negative rods http://www.nirgal.net/life_nano.html

  6. D. Laboratory diagnosis • 3. Culture and identification • b. Colony appearance • i. Swarming of Proteus • indole + P. vulgaris, indole – P. mirabilis • ii. Mucoid Klebsiella • iii. H2S positive Salmonella on Hektoen • iv. Serratia makes a red pigment • v. Yersinia red center with clear border on CIN • c. Identification • i. API strips, automated systems • ii. TSI slants • iii. Salmonella antisera

  7. Enteric gram-negative rods on BAP E. coli Klebsiella sp. http://www.vetmed.wisc.edu/pbs/courses/bact/labmanual/c4klebsiella.html

  8. Enteric gram-negative rods on BAP Proteus sp. http://www.vetmed.wisc.edu/pbs/courses/bact/labmanual/c4klebsiella.html

  9. Identification of Salmonella and Shigella TSI slant Hektoen agar http://www.msu.edu/course/fsc/441/resulex14.html

  10. CIN agar for the recovery of Yersinia sp. http://www.troybio.com/images/Product_Images_BBL/BBL.htm

  11. D. Laboratory diagnosis • 4. Antimicrobial susceptibility testing and therapy • a. Susceptibility is unpredictable, so testing is warranted for extra-intestinal infections • b. Treatment of GI disease with antibiotics is controversial

  12. Vibrio, Aeromonas, Plesiomonas • A. General characteristics • 1. Different from enterics: Oxidase-positive, glucose-ferm, grow on Mac • B. Epidemiology • 1. Reservoirs • a. Vibrio: brackish or salt water • b. Aeromonas: various aquatic environments • c. Plesiomonas: fresh water • 2. Transmission • a. Vibrio: fecal-oral, exposure to contaminated seafood or water • b. Aeromonas: exp. to contam food or water; traumatic injury (fish hooks) • c. Plesiomonas: exp to contam food or water; exp to reptiles

  13. C. Pathogenesis and spectrum of disease • 1. V. cholerae • a. cholera toxin causes mucosal cells to hypersecrete water and electrolytes • b. profuse watery diarrhea, fluid loss, dehydration (rice-water stools: fluid and mucous flecks) • c. somatic O1 and O139 are markers for epidemic/pandemic strains; non O1 or O139 do not produce toxin • 2. Non-cholerae vibrio • a. specific virulence factors undefined • b. gastroenteritis from seafood, wound infections, septicemia • 3. Aeromonas and Plesiomonas • a. virulence factors unclear • b. gastroenteritis, wound infections, septicemia

  14. D. Laboratory diagnosis • 1. Specimen collection, transport, processing • a. no unique requirements except that suspected Vibrio should only be transported in Cary-Blair, because glycerol in buffered glycerol saline is toxic to vibrios • 2. Direct detection methods • a. Vibrios: gnr, slightly curved • b. Aeromonas: gnr, straight • c. Plesiomonas: gnr, single, pairs, short chains, or long filaments

  15. Gram stain of Vibrio sp. http://www2.mf.uni-lj.si/~mil/bakt2/bakt2.htm

  16. D. Laboratory diagnosis • 3. Culture and identification • a. Media • i. all grow on blood and Mac • ii. may be LFs or NLFs • iii. Thiosulfate citrate bile salts sucrose (TCBS); selective media for vibrio: ferments sucrose and makes yellow colonies on blue-green plate. • b. Colony appearance • i. look like gnrs, Aeromonas may be beta-heme • ii. all are OXIDASE-POSITIVE; we look for ox+ positive that are not Pseudomonas • c. Identification • i. API strips or similar

  17. TCBS agar for the recovery of Vibrio sp. http://idsc.nih.go.jp/idwr/kansen/k01_g1/k01_12/k01_12.html

  18. D. Laboratory diagnosis • 4. Antimicrobial susceptibility testing and therapy • a. Tetracycline or doxy are first line drugs for cholera, but fluid management for this and other orgs in main therapy • b. no standardized testing methods for any of these

More Related